{
    "2020-08-07": [
        [
            {
                "time": "",
                "original_text": "又一明星药企剥离非核心业务，重药控股“史上最大规模并购”后再布局！医药行业并购重组潮或已来临？",
                "features": {
                    "keywords": [
                        "明星药企",
                        "剥离非核心业务",
                        "重药控股",
                        "最大规模并购",
                        "医药行业",
                        "并购重组"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "人福医药3.62亿出售四川人福70%股权 将减少有息债务约10亿优化负债结构 资产异常",
                "features": {
                    "keywords": [
                        "人福医药",
                        "出售股权",
                        "四川人福",
                        "减少债务",
                        "优化负债结构",
                        "资产异常"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}